Johnson & Johnson Acquires Omrix Biopharmaceuticals
Johnson & Johnson acquired Omrix Biopharmaceuticals for $432.7M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Johnson & Johnson
- Acquired Company
- Omrix Biopharmaceuticals
- Price
- $432.7M
- Acquisition Type
- Acquisition
- Announced
- November 23, 2008
Canonical: https://fsome.com/acquisitions/johnson-johnson-acquires-omrix-biopharmaceuticals-8204321 · For the full deal terms, timeline, and press references, please enable JavaScript.